Abstract
Cardio-vascular diseases are principal causes of the mortality in the United States. These are closely associated with thrombophilia, and the most prevalent cause of the hereditary thrombophilia is the deficiency or dysfunction of hemostasis related plasma factors. Currently, there is an on-going effort to develop near real-time quantifying methods for the three important molecules related to cardio-vascular diseases in the Department of Chemical Engineering at the University of Louisville. They are: Protein C (PC), Factor V Leiden (FVL), and cardiac Troponin T (cTnT). PC is a key anticoagulant and anti-thrombotic in plasma at the normal concentration of 4 µg/ml. Activated Protein C (APC) achieves its anticoagulant role by inactivating Factor V (FV) and Factor VIII. The heterozygote (less than 60% of the normal level) has an 8-10 fold higher risk of the thrombotic complications by the age of 40 years.’ Currently, PC deficiency is diagnosed by enzyme linked immunosorbent assay (ELISA), which takes at least 6 hours to complete.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Markis, M., Rosendaal, F. R., and Preston, F. E., Familial thrombophiloa:genetic risk factors and management, J. Internal Medicine 242 (Suppl. 740), 9–15 (1997).
Kalafatis, M., Bertina, R. M., Rand, M. D., and Mann, K. G., Characterization of the molecular defect in factor VR506Q, J. Biol. Chem. 270 (8), 4053–4057 (1995).
Appleby, R. D. and Olds, R. J., The inherited basis of venous thrombosis, Pathology 29 341–347 (1997).
Collinson, P., Stubbs, P., Moseley, D., Oakes, M., Greenwood, T., and Noble, M., Measurement of cardiac troponin T for risk stratification in unstable angina, Clin. Chem. 41 165 (1995).
Forest, J. C., Masse, J., and Lane, A., Evaluation of the analytical performance of the Boehringer Mannheim Elecsys 2010 immunoanalyzer, Clin. Biochem. 38 386–393 (1998).
Muller-Bardorff, M., Sylven, C., Rasmanis, G., Jorgensen, B., Collinson, P. 0., Waldenhofer, U., Hirsch!, M. M., Laggner, A. N., Gerhardt, W., Hafner, G., LabaereI. Lenberger, R., Zerback, R., and Katus H. A., Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin, Clin Chem. Lab. Med. 38 (6), 567–574 (2000).
Spiker, J. O. and Kang, K. A., Preliminary study of real-time fiber optic based protein C biosensor, Biotech. Bioeng. 66 (3), 158–163 (1999).
Kwon, H. J., Balcer, H. I., and Kang, K. A., Protein C biosensor sensitivity for biological samples and sensor reusability, Comparative Biochemistry and Physiology Part A, In press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kwon, H.J., Kang, K.A., Peiper, S.C. (2003). Fiber Optic Immunosensors for Cardiovascular Disease Diagnosis. In: Wilson, D.F., Evans, S.M., Biaglow, J., Pastuszko, A. (eds) Oxygen Transport To Tissue XXIII. Advances in Experimental Medicine and Biology, vol 510. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0205-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0205-0_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4964-8
Online ISBN: 978-1-4615-0205-0
eBook Packages: Springer Book Archive